STAAR Surgical Shares Outstanding 2010-2025 | STAA

STAAR Surgical shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
STAAR Surgical Annual Shares Outstanding
(Millions of Shares)
2024 49
2023 49
2022 49
2021 49
2020 48
2019 47
2018 45
2017 41
2016 40
2015 39
2014 38
2013 39
2012 36
2011 37
2010 35
2009 32
STAAR Surgical Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 49
2024-12-31 49
2024-09-30 50
2024-06-30 50
2024-03-31 49
2023-12-31 49
2023-09-30 49
2023-06-30 50
2023-03-31 50
2022-12-31 49
2022-09-30 50
2022-06-30 49
2022-03-31 49
2021-12-31 49
2021-09-30 50
2021-06-30 49
2021-03-31 49
2020-12-31 48
2020-09-30 48
2020-06-30 45
2020-03-31 45
2019-12-31 47
2019-09-30 47
2019-06-30 47
2019-03-31 47
2018-12-31 45
2018-09-30 46
2018-06-30 44
2018-03-31 43
2017-12-31 41
2017-09-30 42
2017-06-30 41
2017-03-31 41
2016-12-31 40
2016-09-30 40
2016-06-30 40
2016-03-31 40
2015-12-31 39
2015-09-30 40
2015-06-30 39
2015-03-31 38
2014-12-31 38
2014-09-30 38
2014-06-30 38
2014-03-31 38
2013-12-31 39
2013-09-30 39
2013-06-30 38
2013-03-31 37
2012-12-31 36
2012-09-30 36
2012-06-30 36
2012-03-31 38
2011-12-31 37
2011-09-30 37
2011-06-30 36
2011-03-31 36
2010-12-31 35
2010-09-30 35
2010-06-30 35
2010-03-31 35
2009-12-31 32
2009-09-30 35
2009-06-30 31
2009-03-31 30
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.827B $0.314B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.300B 21.81
Becton Dickinson (BDX) United States $48.551B 12.02
Cardinal Health (CAH) United States $37.055B 19.41
Labcorp (LH) United States $20.745B 16.83
Straumann Holding AG (SAUHY) Switzerland $20.458B 0.00
West Pharmaceutical Services (WST) United States $15.044B 31.53
Cooper (COO) United States $13.399B 17.27
Align Technology (ALGN) United States $12.939B 25.68
Henry Schein (HSIC) United States $8.467B 14.52
Merit Medical Systems (MMSI) United States $5.534B 26.75
DENTSPLY SIRONA (XRAY) United States $3.113B 9.30
CONMED (CNMD) United States $1.713B 12.82
Lifevantage (LFVN) United States $0.157B 16.17
Pro-Dex (PDEX) United States $0.128B 14.01